Gilla Kaplan, Ph.D.
Board Member
Avalo Therapeutics, Inc. (AVTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gilla Kaplan, Ph.D.
Gilla Kaplan, Ph.D. is recorded as Board Member at Avalo Therapeutics, Inc. (AVTX). Avalo Therapeutics, Inc. reported in an 8-K filed June 8, 2026 that Gilla Kaplan, Ph.D. was appointed Director, effective June 2, 2026. Avalo Therapeutics, Inc. reported in an 8-K filed August 14, 2024 that Gilla Kaplan, Ph.D. was appointed Director, effective August 13, 2024.
“The following nominees were elected to the Board, with the voting results for each nominee as shown:”
“Gilla Kaplan, Ph.D. | 328,758 | 6,022 | —”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Avalo Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Garry A. Neil CEO
- Garry Neil CEO, Board Member
- Michael Cola CEO, Chairman, Board Member
- Michael F. Cola CEO, Board Member
- Peter Greenleaf CEO
- Michael Heffernan Chairman, Board Member
- Sol Barer Chairman, Board Member
- Sol J. Barer Chairman, Board Member
- Chris Sullivan CFO
- Christopher Sullivan CFO, Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.